World Cardiology Market Analysis and Reports | Italy Conference Series

Market Analysis - World Cardiology 2017

Cardiology is a forte of inner medicinal managing issue of the heart is it human or creature. The field incorporates therapeutic analysis and treatment of intrinsic heart imperfections, heart disappointment, coronary vein infection, valvular coronary illness and electrophysiology. Cardiology is concerned with the typical usefulness of the heart and the deviation from a sound heart. Numerous issues include the heart itself yet some are outside of the heart.

Heart Diseases: Leading causes of death and disability in the world :-

At present scenario, cardiovascular disease is one of the leading causes of death and disability in the world. As per the current statistics, more than 17.3 million people die from cardiovascular disease every year. Coronary Heart Disease represents one of the main causes of death in Italy. This accounts for 13% of general mortality and 32% of circulatory system deaths in the country. Therefore there is a need of determining the respective contributions of prevention and therapies to reduce Coronary Heart Disease mortality rates are now days becoming increasingly important for planning future strategies.

Coronary diseases that accounts for 13% of all deaths in Italy cause substantial loss of human life, disability, and long-term dependence on health services and medications. Coronary disease is an important factor causing stroke occurrence during older age. During the present scenario there has been rapid growth in costly medical technology and pharmaceutical treatments for Heart Diseases, as well as substantial public health efforts to reduce the levels of major cardiovascular risk factors.

The high risk of heart disease in the region can also be attributed to an inadequate and the high consumption of fat and carbohydrates.
Some of the other factors causing Cardiovascular Disease are
• Being physically inactive
• Being overweight or obese
• Ancestors of heart disease
• Ethnical background
• Sex – men are more likely to develop cardiovascular disease at an earlier age than women.

Global Cardiac Medical Devices Market Share by Region:-

The global cardiac medical devices market is reached an estimated $65.6 billion by 2015. As per the report forecast for Global cardiovascular devices market by region United States accounts for the highest share of the cardiac devices market at 42.8% followed by the Europe that valued 22.3% of the total market share. China accounts for 6.3% of the market share followed by Russia, Brazil and India. Cardiac rhythm management devices claim the largest share globally of the overall cardiac devices market accounts for nearly 5%. As per the report the 2017 market value and CAGR of Cardiac Rhythm Management Devices (CRM) is estimated to be $22.3 billion at the rate of 9.9%. The second is the Interventional Cardiac Devices (ICD) estimated to grow 15.7 billion at the rate of 10.6% by 2017. Global ECG equipment market value was estimated at over USD 4.0 billion in 2014 and is expected to grow at a CAGR of over 5.9% over the next seven years. Key growth contributing factors of the ECG device market include high incidence rate of heart diseases requiring the need for continuous monitoring, funding to hospitals to improve patient care, and industry players’ concentrate on innovating error-free and improved workflow capabilities devices.

 

Cardiovascular Devices Market Development:

As per the report the 2017 market value and CAGR of Cardiac Rhythm Management Devices (CRM) is estimated to be $22.3 billion at the rate of 9.9%. The second is the Interventional Cardiac Devices (ICD) estimated to grow 15.7 billion at the rate of 10.6% by 2017. Global ECG equipment market value was estimated at over USD 4.0 billion in 2014 and is expected to grow at a CAGR of over 5.9% over the next seven years. Key growth contributing factors of the ECG device market include high incidence rate of heart diseases requiring the need for continuous monitoring, funding to hospitals to improve patient care, and industry players’ concentrate on innovating error-free and improved workflow capabilities devices.

 

    

                                          



Some of the important Companies Mentioned in the Global Cardiovascular Devices are MAQUET GmbH & Co. KG, Sorin Group, Medtronic Inc., EndoPhotonix Inc., Terumo Corporation, SEMMT Inc., C. R. Bard Inc., Cardima Inc., Edwards Lifesciences, CyberHeart Incorporated, MedWaves Incorporated, Kardium Inc., St. Jude Medical and others.

With the success of “World Cardiology Congress” in Dubai, our team is proud to host upcoming “22nd World Cardiology Conference” during December 11-12, 2017 Rome, Italy. The event will bring together world-class cardiologists, researchers and professors to discuss strategies for prevention of coronary disease, stroke and sudden death.

World Cardiology Conference 2017 is designed on the theme: “Accelerating Innovations & fostering advances in Cardio Research” that focuses to share novel approaches related to Cardiology field and exploring the challenges concerning excellence in Cardio research and advancements. The motive of the event is to generate awareness that will keep medical professionals abreast of the problems affecting the prevention, diagnosis and treatment of cardiovascular disease.

World Cardiology Conference is a unique forum to bring together worldwide distinguished academics in the field of cardiology, cardiovascular researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. Expert faculties will discuss the relevant advances in Cardio research and will explore the novel trends to reduce the effects of cardiovascular risk factors.

The aim of this conference is stimulate new ideas for treatment and analyse the current market for the future direction of cardiovascular drugs, devices, and diagnostics, with an emphasis on newer products that will be beneficial across the spectrum of Cardiology. Lectures will provide a comprehensive state-of-the-art update of the clinical uses of various techniques in the diagnosis, prognosis, and management of common cardiovascular diseases.